Biogen Pharmachem Industries Ltd

Biogen Pharmachem Industries Ltd (BIOGEN) is a micro-cap Financial Services company valued at ₹26 crore operating in Other Financial Services on the NSE and BSE.

Recent price move

Biogen Pharmachem Industries Ltd last traded at ₹0.25, down 3.85% on the day.

Financial performance

The company's annual revenue rose 204.8% to ₹3 crore, but the latest quarter revenue fell 71.4% to ₹0 crore compared to the same quarter a year earlier. Annual net profit swung from a net loss of ₹0 crore to a profit of ₹1 crore, but the latest quarter net profit fell 83.6% to ₹0 crore compared to the same quarter a year earlier. The net profit margin improved 68.5 percentage points to 33.6%, while return on equity and return on capital employed remained low at 0.9% and 1.0% respectively.

Valuation multiples

The stock trades at 25.0 times earnings, a premium to the Financial Services median of 19.3, 0.29 times book value.

Things to watch

The company's latest quarter revenue and net profit fell sharply to ₹0 crore, down 71.4% and 83.6% respectively from the same quarter a year earlier. The stock is 69.0% below its 52-week high, and the latest quarter results show a significant drop in performance compared to the prior year.

Where it stands

The company's annual revenue and net profit improved significantly, with revenue rising 204.8% and net profit turning from a loss to a profit. However, the latest quarter results show a sharp decline, with revenue and net profit falling to ₹0 crore. The stock is 69.0% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.